Pharmaceutical preparations containing mixtures of various proteolytic and nonproteolytic enzymes have been suggested for use in the treatment of malignant diseases. However, the mode of action of such preparations was not clear. We have shown before that intact bromelain, papain or amylase, which are components of a commercial polyenzyme preparation, induce cytokine production in peripheral blood mononuclear cells in vitro. IFN-alpha and IFN-gamma which had no effect alone, synergistically increased TNF production when applied together with the enzymes. Here we show that trypsin alone had only a small inducing effect. The tryptic but not the autolytic fragments of papain and bromelain have a higher (10- to 40-fold) inducing capacity for TNF production than the untreated enzyme. Additionally we demonstrate that after ingestion of milligram doses of the polyenzyme preparation (as recommended for clinical use), PBMNC of healthy donors acquire the ability to produce TNF-alpha, IL-1 beta and IL-6 when incubated ex vivo with IFN-gamma. Our results indicate that the biological effects observed after oral administration of polyenzyme preparations are related to their ability to induce cytokine production. This may explain the antitumor effects of such enzymes. Our results also suggest that polyenzyme preparations may have a stronger immunomodulary effect when used in combination with IFN-gamma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000227219 | DOI Listing |
Eur J Pediatr Surg
December 2009
Stavropol State Medical Academy, Pediatric Surgery, 70 /1-15 Shpakovskaya, Stavropol, Russian Federation.
Introduction: Intraperitoneal adhesions remain a common problem after abdominal surgery. However, the advent of targeted, specific agents as a directed therapy against inflammatory and neoangiogenesis raises the prospect of a new approach for anti-adhesion strategies.
Methods: 70 adult rats were divided into two groups: an enzyme group (35 rats) and a control group (35 rats).
Vestn Khir Im I I Grek
June 2009
Adhesive process in the abdominal cavity is the leading cause of morbidity and mortality in abdominal surgery. The clinical investigation included 126 children with acute adhesive intestinal obstruction. All patients were divided into two groups: polyenzyme and monoenzyme groups.
View Article and Find Full Text PDFHindustan Antibiot Bull
January 2009
Advanced Enzyme Technologies Ltd. Thane.
A novel polyenzyme formulation Gumseb developed by Advanced Enzyme Technologies Ltd, Thane and Speciality Biochemicals Co., USA, was tested for antibacterial properties using ATCC strains and clinical isolates of Salmonella typhi, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae. A modified antibiotic susceptibility test was used for the purpose.
View Article and Find Full Text PDFNutr Hosp
December 2007
*Unidad de Nutrición Clínica y Dietética, Hospital Universitario "San Cecilio" de Granada, España.
Introduction: Massive small bowel resection (MSBR) with a remnant jejunum shorter than 60 cm produces severe water, electrolytes, vitamins and protein-caloric depletion. While waiting for a viable intestinal transplantation, most of MSBR patients depend on total parenteral nutrition (TPN).
Clinical Case: 32 years old male, with MSBR due to sectioning trauma of the superior mesenteric artery root.
A new polyenzyme formulation 'Candidaseb' was tested for its ability to inhibit clinically important fungi. After its antifungal activity was established, an assay was standardized to determine whether any potentiation effect was possible if Candidaseb was used in conjunction with three standard antifungal agents viz, Amphotericin B, Miconazole and Ketoconazole against 5 clinically significant fungi viz., Candida albicans, Cryptococcus neoformans, Aspergillusniger, Microsporum gypseum and Trichophyton rubrum.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!